Edition:
United States

Xvivo Perfusion AB (XVIVO.ST)

XVIVO.ST on Stockholm Stock Exchange

165.60SEK
17 Aug 2018
Change (% chg)

0.60kr (+0.36%)
Prev Close
165.00kr
Open
168.40kr
Day's High
168.40kr
Day's Low
164.00kr
Volume
15,000
Avg. Vol
40,457
52-wk High
168.40kr
52-wk Low
82.00kr

Chart for

About

Xvivo Perfusion AB is a Sweden-based medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation. The Company operates in two segments: Durable goods and Non-Durable goods. The Durable goods segment comprises sale and rental income from XVIVO... (more)

Overall

Beta: 0.67
Market Cap(Mil.): kr4,337.15
Shares Outstanding(Mil.): 26.19
Dividend: --
Yield (%): --

Financials

  XVIVO.ST Industry Sector
P/E (TTM): 337.69 38.05 30.45
EPS (TTM): 0.49 -- --
ROI: 2.48 14.28 12.63
ROE: 2.49 17.47 14.82

BRIEF-XVIVO Perfusion Has Submitted Premarket Approval Application For XPS With STEEN Solution To FDA

* XVIVO PERFUSION HAS SUBMITTED PREMARKET APPROVAL APPLICATION FOR XPS WITH STEEN SOLUTION TO FDA Source text for Eikon: Further company coverage:

May 11 2018

BRIEF-Xvivo Perfusion Q1 Adjusted. EBITDA Sek 7.2 Million

* Q1 ADJUSTED. EBITDA SEK 7.2 MILLION VERSUS SEK 5.0 MILLION YEAR AGO

Apr 26 2018

Earnings vs. Estimates